Retinal Disorder Treatment Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028

Published Date : Jan 2021 | No. of Pages : 250 Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Retinal Disorder Treatment Market, By Type

7.1.  Retinal Disorder Treatment Market, By Type, 2021-2028

7.1.1.    Macular Degeneration

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Diabetic Retinopathy

7.1.2.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Retinal Disorder Treatment Market, By Dosage Form

8.1.  Retinal Disorder Treatment Market, By Dosage Form, 2021-2028

8.1.1.    Gels

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Eye Solutions

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Capsules & Tablets

8.1.3.1.        Market Revenue and Forecast (2016-2028)

8.1.4.    Eye Drops

8.1.4.1.        Market Revenue and Forecast (2016-2028)

8.1.5.    Ointments

8.1.5.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Retinal Disorder Treatment Market, By Distribution Channel

9.1.  Retinal Disorder Treatment Market, By Distribution Channel, 2021-2028

9.1.1.    Hospital Pharmacy

9.1.1.1.        Market Revenue and Forecast (2016-2028)

9.1.2.    Online Pharmacy

9.1.2.1.        Market Revenue and Forecast (2016-2028)

9.1.3.    Retail Pharmacy

9.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 10.      Global Retinal Disorder Treatment Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, By Type (2016-2028)

10.1.2.  Market Revenue and Forecast, By Dosage Form (2016-2028)

10.1.3.  Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, By Type (2016-2028)

10.1.4.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.1.4.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, By Type (2016-2028)

10.1.5.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.1.5.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, By Type (2016-2028)

10.2.2.  Market Revenue and Forecast, By Dosage Form (2016-2028)

10.2.3.  Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, By Type (2016-2028)

10.2.4.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.2.4.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, By Type (2016-2028)

10.2.5.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.2.5.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, By Type (2016-2028)

10.2.6.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.2.6.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, By Type (2016-2028)

10.2.7.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.2.7.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, By Type (2016-2028)

10.3.2.  Market Revenue and Forecast, By Dosage Form (2016-2028)

10.3.3.  Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, By Type (2016-2028)

10.3.4.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.3.4.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, By Type (2016-2028)

10.3.5.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.3.5.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, By Type (2016-2028)

10.3.6.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.3.6.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, By Type (2016-2028)

10.3.7.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.3.7.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, By Type (2016-2028)

10.4.2.  Market Revenue and Forecast, By Dosage Form (2016-2028)

10.4.3.  Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, By Type (2016-2028)

10.4.4.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.4.4.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, By Type (2016-2028)

10.4.5.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.4.5.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, By Type (2016-2028)

10.4.6.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.4.6.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, By Type (2016-2028)

10.4.7.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.4.7.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, By Type (2016-2028)

10.5.2.  Market Revenue and Forecast, By Dosage Form (2016-2028)

10.5.3.  Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, By Type (2016-2028)

10.5.4.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.5.4.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, By Type (2016-2028)

10.5.5.2.      Market Revenue and Forecast, By Dosage Form (2016-2028)

10.5.5.3.      Market Revenue and Forecast, By Distribution Channel (2016-2028)

Chapter 11.  Company Profiles

11.1.              Santen Pharmaceutical Co., Ltd

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              REGENERON

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Graybug Vision, Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Shire (Takeda Pharmaceuticals)

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Bayer AG

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Genentech, Inc.

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Acucela Inc.

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Pfizer Inc.

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Healthcare Testing, Inspection, And Certification Outsourcing Market (By Services: Testing, Inspection, Certification; By Type) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Pupillometer Market (By Mobility: Table-top, Hand-held; By Type: Video, Digital; By End-use: Hospitals, Eye Clinics; By Application: Ophthalmology, Oncology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    North America And Europe Preclinical Medical Device Testing Services Market (By Service: Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Cell Banking Outsourcing Market (By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking; By Cell Type; By Phase) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Biologics Contract Development Market (By Source: Mammalian, Microbial; By Product Service Type; By Indication: Oncology, Immunological Disorders) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...